All links accessed on April 22 2026

1. MIND. Mental health facts and statistics. September 2025. https://www.mind.org.uk/information-support/types-of-mental-health-problems/mental-health-facts-and-statistics/

2. NHS England. Digital. ‘Adult Psychiatric Morbidity Survey: Survey of Mental Health and Wellbeing, England. 2023/4’. 27 November 2025. https://digital.nhs.uk/data-and-information/publications/statistical/adult-psychiatric-morbidity-survey/survey-of-mental-health-and-wellbeing-england-2023-24/common-mental-health-conditions

3. NHS Business Services Authority. ‘Medicines Used in Mental Health - Antidepressant drugs England 2015/16 to 2024/25’. 24 July 2025 https://nhsbsa-opendata.s3.eu-west-2.amazonaws.com/mumh/mumh_0403_2425_v001.html

4. NHSBSA. ‘Medicines Used in Mental Health - Antidepressant drugs. England - October to December 2025’ – Table 1. 5 March 2026. https://nhsbsa-opendata.s3.eu-west-2.amazonaws.com/mumh/mumh_quarterly_dec25_0403.html

5. NHSBSA. Statistics and Data Science. ‘Medicines used in mental health – England – 2015/16 to 2024/25’. Published 24 July 2025, updated 15 January 2026. https://www.nhsbsa.nhs.uk/statistical-collections/medicines-used-mental-health-england/medicines-used-mental-health-england-201516-202425

6. College for Pharmacy Postgraduate Education. Providing NHS and public health pharmacy services: NHS New Medicine Service ‘Depression – resources to support your NHS New Medicine Service consultations’.  https://www.cppe.ac.uk/services/nms

7. L Ereshefsky et al. ‘The 6-month persistence on SSRIs and associated economic burden’. Journal of Medical Economics. August 2020. 13;3:527–536. https://www.tandfonline.com/doi/10.3111/13696998.2010.511050

8. RA Elliott et al. ‘Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service’. BMJ Quality & Safety. 2016. 25:747-758. https://qualitysafety.bmj.com/content/25/10/747

9. NHS England. ‘Community pharmacy advanced service specification: NHS new medicine service’. Version 2.0. October 2025.  https://www.england.nhs.uk/long-read/community-pharmacy-advanced-service-specification-nhs-new-medicine-service/

10. NHSBSA. ‘New Medicine Service (NMS) – Drug Lists’. ‘NMS Eligible Drug List’ Excel: 93KB. 29 October 2029 https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/dispensing-contractors-information/new-medicine-service-nms-drug-lists

11. Summaries of Product Characteristics (SmPCs). emc electronic medicine compendium. https://www.medicines.org.uk/emc

12. NHS dm+d browser. ‘Suppliers for Duloxetine 60mg gastro-resistant capsules’. https://dmd-browser.nhsbsa.nhs.uk/vmp/view/9835/suppliers?ref=

13. NICE. BNF. Drugs. https://bnf.nice.org.uk/

14. NICE guideline NG222. ‘Depression in adults: treatment and management’. 29 June 2022. https://www.nice.org.uk/guidance/ng222

15. MHRA. ‘Selective Serotonin Reuptake Inhibitors (SSRI) – 3. Prescribing points’. Last updated 13 February 2015. https://cpd.mhra.gov.uk/ssri/CON146583_4

16. Community Pharmacy England. ‘New Medicine Service (NMS)’. Published on 18 June 2013, updated on 21 April 2026. https://cpe.org.uk/national-pharmacy-services/advanced-services/nms/

17. NHS Scotland. Right Decision Service. ‘Antipsychotics - Extrapyramidal side effects- Management’. Last reviewed 29 November 2024. https://www.rightdecisions.scot.nhs.uk/mypsych-app/working-in-greater-glasgow-clyde/medicines-companion/antipsychotics/extrapyramidal-side-effects-management/

18. NHS. Specialist Pharmacy Service. Identifying risk factors for developing a long QT interval. Published 29 March 2023, last updated 17 February 2026. https://www.sps.nhs.uk/articles/identifying-risk-factors-for-developing-a-long-qt-interval/

19. MHRA. Drug Safety Update. ‘SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery’. 7 January 2021. https://www.gov.uk/drug-safety-update/ssri-slash-snri-antidepressant-medicines-small-increased-risk-of-postpartum-haemorrhage-when-used-in-the-month-before-delivery